CDK 4/6 Inhibition in Breast Cancer: Self-Study Module II

CDK 4/6 Inhibition in Breast Cancer: Self-Study Module II is organized by RealCME.

Primary Audience:
Oncology nurses, nurse navigators, nurse practitioners, physician assistants, medical technicians, and other healthcare professionals involved in the care and management of patients with advanced or metastatic breast cancer.

Credits:
1 ANCC Contact Hours 1 AMA PRA Category 1 Credit(s)™

Learning Objectives:
• Evaluate proper dosing administration, monitoring, and adherence strategies of CDK 4/6 inhibitors for the treatment of estrogen receptor–positive, HER2-negative advanced breast cancer
• Develop education strategies to help patients understand how to recognize and manage side effects of CDK 4/6 inhibitors for the treatment of estrogen receptor–positive, HER2-negative advanced breast cancer
• Describe effective nursing management of adverse events associated with CDK inhibitors

Additional details will be posted as soon as they are available.